First Time Loading...
C

China Isotope & Radiation Corp
HKEX:1763

Watchlist Manager
China Isotope & Radiation Corp
HKEX:1763
Watchlist
Price: 10.1 HKD -9.82% Market Closed
Updated: Mar 29, 2024

China Isotope & Radiation Corp
Revenue

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

China Isotope & Radiation Corp
Revenue Peer Comparison

Comparables:
1066
S
600529
603658
300888
300832

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
C
China Isotope & Radiation Corp
HKEX:1763
Revenue
¥6.1B
CAGR 3-Years
16%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Revenue
¥13.5B
CAGR 3-Years
8%
CAGR 5-Years
13%
CAGR 10-Years
N/A
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Revenue
¥4.9B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
12%
Autobio Diagnostics Co Ltd
SSE:603658
Revenue
¥4.4B
CAGR 3-Years
16%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Revenue
¥11.4B
CAGR 3-Years
35%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Revenue
¥3B
CAGR 3-Years
22%
CAGR 5-Years
22%
CAGR 10-Years
N/A

See Also

What is China Isotope & Radiation Corp's Revenue?
Revenue
6.1B CNY

Based on the financial report for Dec 31, 2022, China Isotope & Radiation Corp's Revenue amounts to 6.1B CNY.

What is China Isotope & Radiation Corp's Revenue growth rate?
Revenue CAGR 5Y
18%

Over the last year, the Revenue growth was 19%. The average annual Revenue growth rates for China Isotope & Radiation Corp have been 16% over the past three years , 18% over the past five years .